Aurora Cannabis Inc. (ACB) Stock
Valuation
Financials & Margins
Annual Financials (USD)
Balance Sheet (USD)
Latest News
Cash Flow (USD)
Valuation & Return Ratios
Ownership
About Aurora Cannabis Inc.
Aurora Cannabis Inc. is led by CEO Miguel Martin, employs 1,073 people, headquartered in CA, publicly traded since 2014.
Aurora Cannabis Inc. (ACB) stock trades at $3.88 with a market capitalization of $245.64M. The stock is valued at a negative price-to-earnings (P/E) ratio of -2.89, reflecting a net loss over the last twelve months, price-to-book of 0.65, price-to-sales of 1.19. Over the past 52 weeks the stock has ranged between $2.56 and $6.67, and currently trades 41.8% below its 52-week high.
On profitability, Aurora Cannabis Inc. generates a return on equity (ROE) of -21.00% (negative, reflecting a net loss), return on capital employed of -15.72%, an operating margin of 1.46%, a net profit margin of -38.15%.
Aurora Cannabis Inc. by the numbers, 2017–2026
Between 2017 and 2026 Aurora Cannabis Inc. reported revenue of $18.0M rising to $321.0M, a change of +1683.3% across 10 years. Compounded, revenue has grown 5.5% a year over five years, 12.7% over three, -6.4% over the last twelve months. Net profit fell to $-122.0M.
Operating margin went from -62.0% in 2017 to -14.6% in 2026, a gain of 47.4 percentage points. The most recent net margin is -38.15%. On a trailing twelve-month basis to Jun '26, revenue is $290.0M and net profit $-110.0M.
Borrowings fell from $64.0M to $24.0M, cash from operations was $-14.0M in the latest year, positive in 1 of the last 10.
Return on equity has averaged -111.3% over five years, and was -23.8% in the most recent year.
The share price itself has compounded at —% a year over five years, —% over three, —% over the last year. Past price movement is history, not a forecast.
Figures are as reported and in the company's own reporting currency. They describe what has already happened and carry no implication about what follows.
Aurora Cannabis Inc. (ACB) — frequently asked questions
What is Aurora Cannabis Inc. (ACB) stock price today?
Aurora Cannabis Inc. (ACB) is currently trading at $3.88, down 2.27% today.
What is ACB P/E ratio?
Aurora Cannabis Inc.'s P/E ratio is -2.89. A negative P/E means the company reported a net loss over the last twelve months, so P/E is not a meaningful valuation measure for it right now.
What is ACB return on equity (ROE)?
Aurora Cannabis Inc.'s return on equity (ROE) is -21.00%. ROE measures net income relative to shareholders' equity. A negative ROE means the company reported a net loss over the period.
What is Aurora Cannabis Inc.'s market cap?
Aurora Cannabis Inc. has a market capitalization of $245.64M.
Does ACB pay a dividend?
Aurora Cannabis Inc. is not currently showing a dividend yield in our data, which means no recent cash dividend was recorded for it.
How much debt does ACB carry?
Aurora Cannabis Inc. has a debt-to-equity ratio of 0.04. That compares total borrowings with shareholders' equity: a figure under 1 means equity exceeds debt.
What is ACB's profit margin?
Aurora Cannabis Inc. reports a net profit margin of -38.15% — the share of revenue left after every cost, including tax and interest.
What sector is ACB in?
Aurora Cannabis Inc. is classified under Healthcare, in the Drug Manufacturers - Specialty & Generic industry. Ratios are most informative compared with other companies in the same industry rather than across the whole market.
Which exchange is ACB listed on?
Aurora Cannabis Inc. trades on NASDAQ under the ticker ACB.
What is ACB's 52-week range?
Over the last year Aurora Cannabis Inc. has traded between $2.56 and $6.67.
Related Healthcare Stocks
Popular Stocks
Screens ACB currently matches
On the figures above, Aurora Cannabis Inc. passes the filters for 6 of our ready-made screens, among them Penny Stocks, Stocks Under $5, Stocks Under $10. Appearing on a screen means the numbers meet its filters today and nothing more; the list is rebuilt whenever the data changes.
Related stock screens
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.